(Reuters) – Moderna Inc said on Monday it has concluded advanced exploratory talks with the European Commission to supply 80 million doses of its COVID-19 vaccine candidate.
The potential agreement provides for an option for member states to buy an additional 80 million doses for a total of up to 160 million doses, the company said.
(Reporting by Ankur Banerjee in Bengaluru; Editing by Arun Koyyur)
